AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33720651 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment supplemented with topical antibacterial drugs
Number of subjects: 107
Study 36084520 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional financial incentive (CFI) - food voucher (~3.5 US dollars) for accepting home-based HIV test
Number of subjects: 24793
Study 36084520 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CFI)
Number of subjects: 24793
Study 33325260 — intervention group
Group type: EXPERIMENTAL
Intervention: Training executive control (experimental group)
Number of subjects: 44
Study 33325260 — intervention group
Group type: COMPARATOR
Intervention: Training processing speed (active control group)
Number of subjects: 44
Study 33325260 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (training executive control)
Number of subjects: 44
Study 33325260 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation assessment during and after the intervention
Number of subjects: 44
Study 35331534 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (8 × 10^9 CFU/day) plus 200 μg/day selenium
Number of subjects: 60
Study 35331534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34231751 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromodulation intervention (not specified in detail)
Number of subjects: 31
Study 32686502 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented acetabular cups
Number of subjects: 26
Study 32686502 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented acetabular cups
Number of subjects: 26
Study 32686502 — intervention group
Group type: COMPARATOR
Intervention: Referent healthy acetabulum
Number of subjects: 26
Study 35844233 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MI training (CT and verum tDCS applied over the right dorsolateral prefrontal cortex)
Number of subjects: 90
Study 35844233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive MI training (CT and sham tDCS)
Number of subjects: 90
Study 35844233 — intervention group
Group type: COMPARATOR
Intervention: Control (sham CT and sham tDCS)
Number of subjects: 90
Study 35844233 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (BDs)
Number of subjects: 90
Study 32616063 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day for three days, followed by 200 mg/day for 11 days
Number of subjects: 714
Study 32616063 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 tablets for three days, followed by one tablet for 11 days)
Number of subjects: 714
Study 36383882 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg oral NAC
Number of subjects: 432
Study 36383882 — intervention group
Group type: EXPERIMENTAL
Intervention: rectal indomethacin 100 mg
Number of subjects: 432
Study 36383882 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg oral NAC plus rectal indomethacin 100 mg
Number of subjects: 432
Study 36383882 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 432
Study 33742692 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich diet (200 mg of nitrate daily from lettuce juice beverage)
Number of subjects: 37
Study 33742692 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo, void of nitrate)
Number of subjects: 37
Study 32924550 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Costus sp. oil
Number of subjects: 50
Study 32924550 — intervention group
Group type: COMPARATOR
Intervention: Topical paraffin (placebo)
Number of subjects: 50
Study 35405335 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (specifics not provided)
Number of subjects: 0
Study 35405335 — intervention group
Group type: COMPARATOR
Intervention: Control (specifics not provided)
Number of subjects: 0
Study 35405335 — intervention group
Group type: EXPERIMENTAL
Intervention: Group sequential enrichment design
Number of subjects: 0
Study 33485836 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week combined ULA functional rehabilitation group (n=19) 3 days per week for 30 minutes
Number of subjects: 38
Study 33485836 — intervention group
Group type: COMPARATOR
Intervention: Traditional health care education protocol group (n=19) once a month for 8 weeks
Number of subjects: 38
Study 34191588 — intervention group
Group type: EXPERIMENTAL
Intervention: HFD
Number of subjects: 6
Study 34191588 — intervention group
Group type: COMPARATOR
Intervention: CH-CD
Number of subjects: 6
Study 34191588 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-CD
Number of subjects: 6
Study 34191588 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-HFD
Number of subjects: 6
Study 34937223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold saline solution (0.9% NaCl)
Number of subjects: 170
Study 34937223 — intervention group
Group type: COMPARATOR
Intervention: Topical ophthalmic proparacaine
Number of subjects: 170
Study 36112790 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure applied to Li4, HT7, and Extra 1 points 30-60 minutes before CA
Number of subjects: 100
Study 36112790 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) did not receive acupressure
Number of subjects: 100
Study 34273676 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg)
Number of subjects: 100
Study 34273676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32143685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous golimumab 2 mg/kg (N=241; week 0, week 4, every 8 weeks)
Number of subjects: 480
Study 32143685 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=239; week 0, week 4, week 12, week 20)
Number of subjects: 480
Study 32143685 — intervention group
Group type: COMPARATOR
Intervention: Placebo→golimumab (after week 24)
Number of subjects: 480
Study 34602038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates protocol (8 weeks, 2 visits per week)
Number of subjects: 44
Study 34602038 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 34258264 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Oral Contraceptive (COC) pills (3 mg drospirenone and 0.03 mg ethinyl estradiol daily for 6 weeks)
Number of subjects: 36
Study 34258264 — intervention group
Group type: COMPARATOR
Intervention: No-treatment
Number of subjects: 36
Study 34258264 — intervention group
Group type: COMPARATOR
Intervention: Control (women without endometrioma)
Number of subjects: 36
Study 34878526 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care
Number of subjects: 951
Study 34878526 — intervention group
Group type: COMPARATOR
Intervention: Stepped care
Number of subjects: 951
Study 32991872 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasch-rescaled UEFM
Number of subjects: 361
Study 32991872 — intervention group
Group type: COMPARATOR
Intervention: Raw UEFM
Number of subjects: 361
Study 32065946 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation (BA) plus an exercise prescription
Number of subjects: 29
Study 32065946 — intervention group
Group type: COMPARATOR
Intervention: Behavioral activation (BA) plus a stretching prescription
Number of subjects: 29
Study 36096125 — intervention group
Group type: EXPERIMENTAL
Intervention: ePLND
Number of subjects: 272
Study 36096125 — intervention group
Group type: COMPARATOR
Intervention: No PLND
Number of subjects: 272
Study 33867065 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lecture
Number of subjects: 130
Study 33867065 — intervention group
Group type: EXPERIMENTAL
Intervention: Jigsaw approach
Number of subjects: 130
Study 33867065 — intervention group
Group type: EXPERIMENTAL
Intervention: Fishbowl approach
Number of subjects: 130
Study 32424621 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced illusory control through manipulation of the base-rate of positive outcomes
Number of subjects: 0
Study 32424621 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34995124 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 68
Study 34995124 — intervention group
Group type: COMPARATOR
Intervention: Transoral robotic surgery plus neck dissection (TORS + ND)
Number of subjects: 68
Study 33119135 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insulin index algorithm
Number of subjects: 15
Study 33119135 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate counting
Number of subjects: 15
Study 32483939 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate (Glue group)
Number of subjects: 26
Study 32483939 — intervention group
Group type: COMPARATOR
Intervention: Non-use of 2-octyl cyanoacrylate (non-Glue group)
Number of subjects: 26
Study 35959593 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (white capsule)
Number of subjects: 19
Study 35959593 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocebo (yellow capsule)
Number of subjects: 19
Study 35959593 — intervention group
Group type: COMPARATOR
Intervention: Control (no capsule)
Number of subjects: 19
Study 33319950 — intervention group
Group type: EXPERIMENTAL
Intervention: ORi-based oxygen (group O)
Number of subjects: 50
Study 33319950 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative oxygen (group C)
Number of subjects: 50
Study 32433165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed low dose (FLD) of 259 MBq of I
Number of subjects: 92
Study 32433165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed high dose (FHD) of 555 MBq of I
Number of subjects: 92
Study 32433165 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) to deliver 5.55 MBq/g of I
Number of subjects: 92
Study 35028314 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine orally
Number of subjects: 80
Study 34814839 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile-enriched MBI
Number of subjects: 30
Study 34814839 — intervention group
Group type: COMPARATOR
Intervention: Active MBI
Number of subjects: 30
Study 36326308 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 60
Study 36326308 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study 32970104 — intervention group
Group type: EXPERIMENTAL
Intervention: Plinabulin 20 mg/m2 on day 1
Number of subjects: 55
Study 32970104 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg on day 2
Number of subjects: 55
Study 34718548 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard treatment for frailty
Number of subjects: 0
Study 34718548 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic administration of umbilical cord-derived MSCs (UC-MSCs)
Number of subjects: 0
Study 32394652 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic-acupuncture therapy and rehabilitation training
Number of subjects: 60
Study 32394652 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture and rehabilitation training
Number of subjects: 60
Study 35617712 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based multimedia intervention (multimedia health talk)
Number of subjects: 320
Study 35617712 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list control)
Number of subjects: 320
Study 35617712 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based multimedia intervention
Number of subjects: 320
Study 35617712 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study 34437550 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability matching in a binary lottery game
Number of subjects: 0
Study 34437550 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with experience in probability and statistics
Number of subjects: 0
Study 35504312 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy using a novel approach that combines computational modeling and deep learning.
Number of subjects: 0
Study 34882200 — intervention group
Group type: EXPERIMENTAL
Intervention: 72 hours of cooling (group A)
Number of subjects: 120
Study 34882200 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 hours of cooling (group B)
Number of subjects: 120
Study 34882200 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrographic seizures during rewarming
Number of subjects: 120
Study 34092635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AT)
Number of subjects: 415
Study 34092635 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 415
Study 34092635 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT)
Number of subjects: 415
Study 34092635 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise training (CT)
Number of subjects: 415
Study 32658536 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing cigarettes per day (CPD)
Number of subjects: 68
Study 32658536 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-nicotine-content (VLNC) cigarettes
Number of subjects: 68
Study 32239448 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training (weekly sessions for 8 weeks)
Number of subjects: 46
Study 32239448 — intervention group
Group type: COMPARATOR
Intervention: Blood circulation training exercises (control group)
Number of subjects: 46
Study 36040772 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin treatment (25 mg oral administration) with psychological support for 5-8 hours
Number of subjects: 0
Study 36040772 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin treatment
Number of subjects: 0
Study 33751046 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (VAS)
Number of subjects: 2831
Study 33751046 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A status assessment
Number of subjects: 2831
Study 33751046 — intervention group
Group type: EXPERIMENTAL
Intervention: MRDR assessment
Number of subjects: 2831
Study 33751046 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum carotenoids measurement
Number of subjects: 2831
Study 34169678 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with funding statements
Number of subjects: 0
Study 34169678 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs over time (1979 to 2017)
Number of subjects: 0
Study 34169678 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatments
Number of subjects: 0
Study 33410359 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 175
Study 33410359 — intervention group
Group type: COMPARATOR
Intervention: Informed Decision Making (IDM)
Number of subjects: 175
Study 35368138 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous remote monitoring (CRM) of patients' vital signs
Number of subjects: 0
Study 34101299 — intervention group
Group type: EXPERIMENTAL
Intervention: Keele STarT MSK Tool
Number of subjects: 2414
Study 36320214 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized licorice syrup as an adjuvant treatment plus standard care (Syrup Group, N = 91)
Number of subjects: 213
Study 36320214 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (Standard Group, N = 104)
Number of subjects: 213
Study 33942115 — intervention group
Group type: EXPERIMENTAL
Intervention: LGBT adults
Number of subjects: 1711
Study 34501476 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 30 min moderate-intensity aerobic exercise bout
Number of subjects: 92
Study 34501476 — intervention group
Group type: COMPARATOR
Intervention: Control group (sat and read for 30 min)
Number of subjects: 92
Study 32442971 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick, diffuse subarachnoid hemorrhage (SAH)
Number of subjects: 572
Study 32442971 — intervention group
Group type: COMPARATOR
Intervention: Less hemorrhage burden (no thick, diffuse SAH)
Number of subjects: 572
Study 32442971 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick, diffuse SAH
Number of subjects: 572
Study 33401676 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports smart bracelets and multi-component exercise program
Number of subjects: 60
Study 33401676 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 35234840 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 24081
Study 35234840 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 24081
Study 35234840 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 24081
Study 32789561 — intervention group
Group type: EXPERIMENTAL
Intervention: Common mental disorders (anxiety, depression, PTSD)
Number of subjects: 1678
Study 32789561 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic, health and post-displacement variables
Number of subjects: 1678
Study 32789561 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime history of mental health treatment and problems accessing adequate healthcare
Number of subjects: 1678
Study 36028878 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosemary cream
Number of subjects: 80
Study 36028878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34545545 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (gemcitabine and cisplatin) for 6 cycles
Number of subjects: 50
Study 34545545 — intervention group
Group type: COMPARATOR
Intervention: Surveillance alone (control group)
Number of subjects: 50
Study 32011378 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial drape
Number of subjects: 1659
Study 32011378 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial drape (Control)
Number of subjects: 1659
Study 32049215 — intervention group
Group type: EXPERIMENTAL
Intervention: Creation of four concept maps
Number of subjects: 77
Study 35881301 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous exercise and cognitive training
Number of subjects: 35
Study 35881301 — intervention group
Group type: COMPARATOR
Intervention: Exercise training
Number of subjects: 35
Study 35881301 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 35
Study 33605025 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyebrow tattooing (ET)
Number of subjects: 28
Study 33605025 — intervention group
Group type: COMPARATOR
Intervention: Non-eyebrow tattooing (NET)
Number of subjects: 28
Study 34711947 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin plus paclitaxel (ACP)
Number of subjects: 1202
Study 34711947 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP)
Number of subjects: 1202
Study 34711947 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab plus carboplatin plus paclitaxel (BCP)
Number of subjects: 1202
Study 34711947 — intervention group
Group type: COMPARATOR
Intervention: Comparison of atezolizumab arms (ACP plus ABCP) vs BCP
Number of subjects: 1202
Study 34711947 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ABCP vs BCP
Number of subjects: 1202
Study 34021888 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior block + general anesthesia + patient‐controlled serratus anterior plane block (PCSAPB group)
Number of subjects: 84
Study 34021888 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior block + general anesthesia + patient‐controlled intravenous analgesia (PCIA group)
Number of subjects: 84
Study 34021888 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia + PCIA (control group)
Number of subjects: 84
Study 32345788 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + MPA therapy
Number of subjects: 27347
Study 32345788 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE-alone therapy
Number of subjects: 27347
Study 32345788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27347
Study 32345788 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen hormone therapy (HT)
Number of subjects: 27347
Study 35360984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannula group (short peripheral intravenous cannula with straight-tip guide-wire)
Number of subjects: 130
Study 35360984 — intervention group
Group type: COMPARATOR
Intervention: Needle group (needle with J-tip guide-wire)
Number of subjects: 130
Study 35360984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannula group
Number of subjects: 130
Study 35360984 — intervention group
Group type: COMPARATOR
Intervention: Needle group
Number of subjects: 130
Study 33094728 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (EMPA) 25 mg/day for 24 weeks
Number of subjects: 57
Study 32493872 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (30 minutes daily for 6 months)
Number of subjects: 0
Study 32493872 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with 30 minutes of quiet rest (control)
Number of subjects: 0
Study 35113605 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based organizations and community clinics screening for mental health
Number of subjects: 1057
Study 35113605 — intervention group
Group type: COMPARATOR
Intervention: Compared to non-Latinx Whites
Number of subjects: 1057
Study 34640575 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle training (volitional protrusion against resistance)
Number of subjects: 68
Study 34640575 — intervention group
Group type: COMPARATOR
Intervention: Sham group (negligible resistance)
Number of subjects: 68
Study 34640575 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle training
Number of subjects: 68
Study 34640575 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 68
Study 35048627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg tablets one time per day for 7 days
Number of subjects: 89
Study 35048627 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diazepam)
Number of subjects: 89
Study 33984786 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation
Number of subjects: 118
Study 33984786 — intervention group
Group type: COMPARATOR
Intervention: Short-term personal exposure to air pollutants
Number of subjects: 118
Study 33031185 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined trabeculotomy-trabeculectomy (CTT) with mitomycin-C (MMC)
Number of subjects: 30
Study 33031185 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin-C (MMC)
Number of subjects: 30